DRKS00011877已完成不适用
Survey of a representative sample of patients after topicala) capsaicin 8% therapyb) lidocaine 5% therapyc) botulinum toxin A injection
Berufgenossenschaftliches Universitätsklinikum Bergmannsheil gGmbH, Abteilung für Schmerzmedizin0 个研究点目标入组 224 人开始时间: 2017年5月4日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 224
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- one 至 one（—）
- 性别
- All
入选标准
- •All patients who a) received at least one treatment with the topical capsaicin 8% (Qutenza ®) in the own clinic since 2010 b) since 2008 received at least one Versatis® therapy in the own clinic c) since 2014 received at least one Botox® injection in the own clinic
排除标准
- •lack of ability to provide information, cognitive limitations
研究者
相似试验
已完成
不适用
Clinical study using samples of patients experienced systemic side effects by vaccinessystemic side effects by vaccinesJPRN-UMIN000013052ational Institutes of Biomedical Innovation,Health and Nutrition2
已完成
不适用
Clinical study using samples of patients experienced side effects by influenza vaccinesystemic side effect of vaccinesJPRN-UMIN000013064ational Institutes of Biomedical Innovation,Health and Nutrition31
招募中
不适用
A prospective observational study for patients with community-acquired, health-care-associated, hospital-acquired, and ventilator-associated pneumonia in a Japanese University Hospitalcommunity-acquired (CAP), health-care-associated (HCAP), hospital-acquired (HAP), and ventilator-associated pneumonia (VAP)JPRN-UMIN000007090Department of Respiratory Medicine, Nagoya University Graduate School of Medicine1,420
招募中
不适用
Actual condition survey for the patients with type 2 diabetes mellitus and examination of both predictive and exacerbating factors for nonalcoholic fatty liver disease and arteriosclerotic disease in type 2 diabetes mellitusonalcoholic fatty liver disease (NAFLD) Nonalcoholic steatohepatitis (NASH) Type 2 diabetes mellitus Cardiovascular disease Arteriosclerotic diseaseJPRN-UMIN000041029Ehime University4,000
尚未招募
Unknown
A Prospective Observational Study of patients who switched from SGLT2 inhibitor tablets to luseogliflozin OD film formulation in terms of feeling, Efficacy and Safety of taking the medicine.Type 2 Diabetes MellitusJPRN-UMIN000050476Seino internal Medicine Clinic60